As the levels of PPY, NAMPT, ADIPOQ, IL34, RAC3, TAP1, AHNAK, PDGFRA and the risk score increased, the pathological grade of BLCA patients increased (p < 0.01) (Figure 10A–10I). The gene discussed is IL34; the disease is bladder transitional cell carcinoma.